BARD AVAULTA CLAIMS:
VAGINAL MESH PROBLEMS
The Bard Avaulta lawyers at Davis & Crump are investigating potential claims for women who were implanted with a Bard Avaulta mesh to treat pelvic organ prolapse (POP) and suffered severe internal injuries. Cases are being evaluated for women who have experienced complications following surgery with the Bard Avaulta system and for women who are uncertain what type of vaginal mesh was surgically implanted.
Bard Avaulta mesh claims are being reviewed for women who have experienced:
Infection
Erosion of the mesh into the vagina
Urinary problems
Pelvic Pain
Vaginal Pain
Hardening of the vaginal mesh
Injury to nearby organs
Difficulty during sex after vaginal surgery.
The Bard Avaulta Anterior and Posterior Biosynthetic Support System, also commonly referred to as Bard Avaulta Mesh or Bard Avaulta System, is a vaginal mesh created by C. R. Bard to correct and restore normal vaginal structure after a pelvic organ prolapse (POP).
Pelvic organ prolapse, which sometimes occurs in women after childbirth or surgery, causes the womb to fall into the vaginal area. This can also lead to the bladder and bowels slipping out of place and putting pressure on the vagina, which causes pain and discomfort, as well as urinary incontinence in some cases. However, a growing number of women treated with the Bard Avaulta system have indicated that defects in the design of the vaginal mesh caused them to suffer severe injuries and complications after surgery.
Synthetic mesh systems like the Bard Avaulta have been linked to numerous reports of problems, most frequently involving erosion, extrusion, infection, hardening of the mesh, chronic pain and damage to surrounding organs. At the 2004 World Health Organization 3rd International Consultation on Incontinence, it was reported that vaginal mesh procedures have an unacceptably high rate of complications. As a result of the risks, it was recommended that synthetic mesh systems not be used until more approved clinical trials were conducted.
Although the manufacturer, C. R. Bard, knew or should have known about the risk of problems with Bard Avaulta mesh, they continued to market and promote the product as a safe and effective treatment of pelvic organ prolapse, while minimizing the risks of a Bard procedure.
The Bard Avaulta is designed to allow tissue infiltration, which makes it very dangerous and complicated to remove the vaginal mesh. Complications from Bard Avaulta and from mesh removal are life-changing and can be irreversible. Removal of eroded or infected
Bard Avaulta mesh poses a risk of permanent disfigurement, hemorrhage and other potentially life-threatening problems. Complete Bard Avaulta mesh removal often requires multiple surgery procedures and results in scarring of pelvic tissue and muscles.
Bard Avaulta lawsuits allege that C. R. Bard was negligent in the design and safe use of the Avaulta system. Since the vaginal mesh was introduced, the manufacturer knew or should have known that the Bard Avaulta mesh was defective and could lead to erosion, hardening and shrinkage of the mesh materials and other complications that may have a devastating impact on women.
Despite the known risks of Bard Avaulta mesh complications, the manufacturer failed to adequately research the product and establish that it provides both long term and short term efficacy. In addition, they concealed known risks and failed to warn of the dangers and risks with Bard Avaulta mesh for pelvic organ prolapse.
Contact a Bard Avaulta Mesh Attorney Today.
Davis & Crump is now handling claims for individuals who have been injured by a Bard Avaulta Mesh. Davis & Crump is experienced in medical device product liability cases and settlements. If you or a loved one has been injured by a Bard Avaulta mesh, contact us at 1-800-277-0300 or send us an email at info@daviscrump.com.